Amgen Inc. (AMGN)
NASDAQ
437.23
-6.89 (-1.55%)
Closed
Sep 4, 2026
Day's Range
435.00441.85
52 wk Range
269.77447.03
Financial Statements - AMGN - Amgen Inc.
Revenue
36.75B▲ 10.0%
Net Income
7.71B▲ 88.5%Net Margin 21.0%
EBITDA
16.89B▲ 26.5%
Free Cash Flow
8.10B▼ 22.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 36.75B | 33.42B | 28.19B | 26.32B | 25.97B | 25.42B |
| Cost of Goods | 12.03B | 12.85B | 8.45B | 6.40B | 6.45B | 6.15B |
| Gross Profit | 24.71B | 20.56B | 19.73B | 19.91B | 19.52B | 19.26B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 9.08B | 7.25B | 7.89B | 9.56B | 9.14B | 9.13B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 2.65B | 506M | 2.83B | -814M | -1.24B | 256M |
| Pre Tax Income | 8.97B | 4.60B | 7.85B | 7.34B | 6.70B | 8.13B |
| Income Tax | 1.26B | 519M | 1.13B | 794M | 808M | 869M |
| Net Income | 7.71B | 4.09B | 6.71B | 6.55B | 5.89B | 7.26B |
| EPS Basic | 14.33 | 7.62 | 12.56 | 12.18 | 10.34 | 12.4 |
| EPS Diluted | 14.23 | 7.56 | 12.49 | 12.11 | 10.28 | 12.31 |
| Basic Shares Outstanding | 538M | 537M | 535M | 538M | 570M | 586M |
| Diluted Shares Outstanding | 538M | 537M | 535M | 538M | 570M | 586M |
| Ebit | 11.73B | 7.76B | 10.73B | 8.75B | 7.89B | 9.39B |
| Ebitda | 16.89B | 13.35B | 14.80B | 12.16B | 12.80B | 12.99B |
| Net Income Continuous Operations | 7.71B | 4.09B | 6.71B | 6.55B | 5.89B | 7.26B |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
